Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and spectri phase 3 randomized clinical trials

the Chroma and Spectri Study Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)666-677
Number of pages12
JournalJAMA Ophthalmology
Volume136
Issue number6
DOIs
StatePublished - Jun 2018

ASJC Scopus Subject Areas

  • Ophthalmology

Cite this